GMO Archives

zika mosquito oxitcec fda swarm florida trial genetic engineering infectious disease

News and Trends 14 Mar 2016

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US – and stop the spread of Dengue and Zika. As a spin-off from Oxford University, Oxitec specialises in using genetic engineering to control insect pest populations with the ‘Sterile Insect Technique’. This is an interesting alternative to pesticides […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

syngenta hong kong china monsanto biotech agribusiness

News and Trends 2 Mar 2016

Chinese Chemical Giant moves closer to buy Swiss Syngenta for €39.5Bn

Following Monsanto’s failed second attempt to merge with Syngenta, the Chinese seems to have better luck swaying this European chemical giant. Now ChemChina has its looking to secure a multi-billion loan facility for the acquisition. Syngenta is a well known agribusiness leader in agriculture and seeds production. This Swiss agro-tech was born in 2000 after the merger […]

March 2, 2016 - 2 minutesmins - By Joachim Eeckhout

italy agriculture biotech fund crea cisgenesis gmo

News and Trends 18 Feb 2016

Italy Bets on Agriculture and Invests €21M in Sustainable-Biotech

Italian agriculture is booming with Innovation. To boost the creation of cutting-edge products and increase competition between businesses, €21M has been provided by the Italian government to fund sustainable biotechnology and research. The three-year plan focuses on the Council for Agricultural Research and Agricultural Economics Analysis (CREA), a specialized research centre in Rome which is collaborating with the […]

February 18, 2016 - 3 minutesmins - By Joachim Eeckhout

maurizio montalti bioart synthetic bio biotech

News and Trends 2 Dec 2015

How Can BioArt Help Geneticists and the Biotech Field?

BioArt is a hot interdisciplinary sub-genre springing up in Galleries all over Europe. Here is a summary of a review on the movements increasing relevance to the Biotech Industry… In part thanks to the Biohacking and DIY Biotech movement, accessibility to lab equipment, 3D-printers, and the popularity of the Synthetic Biology iGEM Competition, artists around […]

December 2, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 5 Nov 2015

German Bioinformatics Start-Up wants to Change Studies of GMO Crops

High-Tech Grüenderfonds (HTGF) has invested in a spin-off from the Max Planck Institute for Developmental Biology and University of Tübingen. Computomics’ has a pioneering agricultural project involving next generation sequencing (NGS) of GMO crops. Computomics is the biotech which has caught HTGF’s interest. Based in Tübingen (Germany), this bio-informatics start-up tackle genomic analysis of agricultural […]

November 5, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 30 Oct 2015

Purple GMO Tomatoes are Growing Medicines in the UK

Meet the purple tomatoes which produce as much Revervesterol in a single fruit as 50 bottles of wine, and as much anti-breast cancer chemical as 2.5Kg of Tofu! The John Innes Centre in Norwich (East England) have engineered these tomato plants to produce larger amounts of these health-related compounds. With funding from the Biotechnology and […]

October 30, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Sep 2015

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

New GMO rice variety has an increased starch content coupled with low greenhouse gas emissions. By making these GM rices more eco-friendly as well as improving their nutritional value, this research could potentially sway the public and political stigma against this life-altering technology, in the mission to save millions. As we all know, grains such as Golden […]

September 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 10 Aug 2015

Oxitec’s revolutionary Genetically Modified Insects acquired by Intrexon for €146M

Oxitec‘s self-limiting gene technique, which is designed to exterminate dangerous insects, has a price now: $160M (€146M). US-based Intrexon absorbed the Oxford University’s spinout with its unique technology to accelerate the crackdown of dengue infections and crop damages. As we reported early this year, Intrexon Corporation recently partnered across diverse markets, all being part of […]

August 10, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 6 Aug 2015

Here are 7 Biotech Stories you Must Read During the Holidays

The Holidays are a perfect time to enjoy the sun and relax peacefully on the beach but it’s also a great time to read inspiring stories about your favorite topic, Biotechs! For your delight, we bring you the most read biotech stories of this year. Discover or re-discover them and enjoy! January – The CRISPR’s Therapeutical revolution Six […]

August 6, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Jul 2015

Genetically Modified Insects: Designed to Cause Extinction

Insects can be very dangerous creatures, spreading diseases and destroying the yield. The British biotech company Oxitec developed a unique approach to potentially wipe out some harmful populations of these tiny animals. Studies on the diamondback moth are already showing good results! Farmers around the world struggle with a serious pest caused by the diamondback moth […]

July 21, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 13 May 2015

Syngenta rejects Monsanto’s €40-Billion takeover offer

Syngenta has rejected Monsanto‘s merger proposal… again. The American colossus made an offer that Syngenta declined, as the Swiss crop developer considered that Monsanto’s €40Bn bid (CHF 41.7 billion) simply was not enough. The gossip started last week as Monsanto may have done a second attempt to buy Swiss Syngenta. Turns out, the rumors were true, but the negotiations lead […]

May 13, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 29 Apr 2015

European GMOs: which side are you on?

Last week, the European Commission approved 19 GMOs, the first authorizations since 2013. Shortly after, different reactions showed up, with some people more willing to celebrate than others. While GMOs are widely grown in America and Asia, Europe is still reluctant to this new technology. These authorizations came after a year of European blockage. But […]

April 29, 2015 - 3 minutesmins - By Lourdes Riquelme

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

GMO

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Chinese Chemical Giant moves closer to buy Swiss Syngenta for €39.5Bn

Italy Bets on Agriculture and Invests €21M in Sustainable-Biotech

How Can BioArt Help Geneticists and the Biotech Field?

German Bioinformatics Start-Up wants to Change Studies of GMO Crops

Purple GMO Tomatoes are Growing Medicines in the UK

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

Oxitec’s revolutionary Genetically Modified Insects acquired by Intrexon for €146M

Here are 7 Biotech Stories you Must Read During the Holidays

Genetically Modified Insects: Designed to Cause Extinction

Syngenta rejects Monsanto’s €40-Billion takeover offer

European GMOs: which side are you on?

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!